Skip to main content

Advertisement

Table 1 Baseline characteristics of women enrolled in SP in vivo efficacy study, Burkina-Faso and Mali

From: Parasite clearance following treatment with sulphadoxine-pyrimethamine for intermittent preventive treatment in Burkina-Faso and Mali: 42-day in vivo follow-up study

  Burkina-Faso Mali All
  N=312 N =268 N=580
Age, years,    
Mean (SD) 23.6 (5.4) 21.1 (5.1) 22.5 (5.4)
Residing in rural area, n (%) 81 (30.2) 146 (45.2) 222 (38.3)
Knows the date of LMP, n (%) 44 (16.4) 61 (19.6) 105 (18.1)
Pregnancy number    
Median (range) 2 (1–8) 2 (1–9) 2 (1–9)
First or second pregnancy, n (%) 204 (65.4) 185 (69.0) 389 (67.1)
Use of a bed net last nighta    
Any net, n (%) 187 (60.1) 207 (77.2) 394 (68.1)
ITN, n (%) 171 (55.0) 180 (67.2) 351 (60.6)
Use medicine in first trimester    
Any medicine, n (%) 6 (1.9) 25 (9.3) 31(5.3)
Antimalarial, n (%) 2 (0.6) 15 (5.6) 17 (2.9)
Fundal height, cm    
Mean (SD) 21.5 (2.9) 21.8 (3.2) 21.7 (3.1)
Gestational age, weeks    
Mean (SD) 25.3 (3.1) 25.4 (3.2) 25.3 (3.1)
Maternal height, cm    
Mean (SD) 162.7 (6.2) 162.2 (6.3) 162.4 (6.2)
Maternal weight, kgs    
Mean (SD) 57.8 (7.5) 56.4 (8.5) 57.2 (8.0)
Haemoglobin, g/dLb    
Mean (SD) 10.1 (1.4) 9.6 (1.6) 9.9 (1.5)
Anaemia (Hb <11 /dL), n (%) 225 (72.4) 198 (80.5) 423 (75.9)
Moderate-Severe anaemia (Hb <8g/dL), 22 (7.1) 40 (16.3) 62 (11.1)
n (%)    
Peripheral parasitaemia 623 716 664
GMPD/μl (95% CI) (537–723) (598–859) (592–746)
  1. Notes: Data are n0. (%), unless otherwise indicated.
  2. N, sample size; n, number of events; SD, Standard deviation; LMP, Last Menstrual Period; ITN, Insecticide Treated Net; cm, centimeters; kgs, kilograms; g/dL, Gram per deci-Litre; Hb, Haemoglobin; GMPD/μl, Geometric Mean Parasite Density per microlitre.
  3. aBed net use was not evaluated in 1 subject from Burkina-Faso.
  4. bHaemoglobin was not measured for 1 subject in Burkina-Faso and 22 subjects in Mali.